X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs AUROBINDO PHARMA - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. AUROBINDO PHARMA WOCKHARDT LTD./
AUROBINDO PHARMA
 
P/E (TTM) x -15.6 14.2 - View Chart
P/BV x 2.6 3.6 70.0% View Chart
Dividend Yield % 1.3 0.4 301.7%  

Financials

 WOCKHARDT LTD.   AUROBINDO PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
AUROBINDO PHARMA
Mar-17
WOCKHARDT LTD./
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,129895 126.1%   
Low Rs627622 100.8%   
Sales per share (Unadj.) Rs363.1254.6 142.6%  
Earnings per share (Unadj.) Rs-20.439.3 -52.1%  
Cash flow per share (Unadj.) Rs-7.046.6 -15.0%  
Dividends per share (Unadj.) Rs10.002.50 400.0%  
Dividend yield (eoy) %1.10.3 345.6%  
Book value per share (Unadj.) Rs301.8160.0 188.7%  
Shares outstanding (eoy) m110.55585.88 18.9%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x2.43.0 81.2%   
Avg P/E ratio x-42.919.3 -222.4%  
P/CF ratio (eoy) x-125.916.3 -773.0%  
Price / Book Value ratio x2.94.7 61.3%  
Dividend payout %-48.96.4 -768.4%   
Avg Mkt Cap Rs m97,063444,390 21.8%   
No. of employees `0006.814.0 48.4%   
Total wages/salary Rs m9,66517,678 54.7%   
Avg. sales/employee Rs Th5,931.810,667.8 55.6%   
Avg. wages/employee Rs Th1,428.11,264.3 113.0%   
Avg. net profit/employee Rs Th-334.01,645.8 -20.3%   
INCOME DATA
Net Sales Rs m40,146149,157 26.9%  
Other income Rs m1,1431,159 98.6%   
Total revenues Rs m41,289150,316 27.5%   
Gross profit Rs m12834,343 0.4%  
Depreciation Rs m1,4894,276 34.8%   
Interest Rs m2,253667 337.6%   
Profit before tax Rs m-2,47230,558 -8.1%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2117,597 -2.8%   
Profit after tax Rs m-2,26023,012 -9.8%  
Gross profit margin %0.323.0 1.4%  
Effective tax rate %8.524.9 34.4%   
Net profit margin %-5.615.4 -36.5%  
BALANCE SHEET DATA
Current assets Rs m46,16092,062 50.1%   
Current liabilities Rs m19,25866,223 29.1%   
Net working cap to sales %67.017.3 386.8%  
Current ratio x2.41.4 172.4%  
Inventory Days Days101106 95.1%  
Debtors Days Days9468 139.0%  
Net fixed assets Rs m40,16562,919 63.8%   
Share capital Rs m553586 94.3%   
"Free" reserves Rs m32,81493,133 35.2%   
Net worth Rs m33,36793,719 35.6%   
Long term debt Rs m31,9031,814 1,758.7%   
Total assets Rs m89,687162,494 55.2%  
Interest coverage x-0.146.8 -0.2%   
Debt to equity ratio x1.00 4,939.7%  
Sales to assets ratio x0.40.9 48.8%   
Return on assets %014.6 -0.1%  
Return on equity %-6.824.6 -27.6%  
Return on capital %-0.332.7 -1.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,12175,838 12.0%   
Fx outflow Rs m2,13330,224 7.1%   
Net fx Rs m6,98845,613 15.3%   
CASH FLOW
From Operations Rs m-2,69532,786 -8.2%  
From Investments Rs m-6,863-17,870 38.4%  
From Financial Activity Rs m12,545-19,153 -65.5%  
Net Cashflow Rs m3,010-4,239 -71.0%  

Share Holding

Indian Promoters % 74.5 54.1 137.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 8.0 28.9%  
FIIs % 7.7 27.7 27.8%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 10.2 151.0%  
Shareholders   67,757 69,601 97.4%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Feb 19, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - MERCK LTD COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS